comprehensive -WSS

comprehensive

author：focus 2025-09-06 06:17:00 - browse：23931

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： World's first CRISPR

explore

WSS

A letter from the executive editor: The 2023 STATUS List

Drug cartel violence flares in western Mexico after vigilante leader's killing

Childhood cancer progress stalls for Black, Hispanic kids: Report

Lupron, used to halt puberty in children, may cause lasting health problems

Wegovy, Zepbound and weight loss drugs that preserve muscle

Why medical students are struggling with mental health

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Affirmative action in medical school literally saved lives

Readout LOUD podcast: A CRISPR milestone, biotech mixology

The cancer drug shortage isn’t new — and neither are the solutions

Astellas still sees hope in its gene therapy after four deaths

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Tori Bowie and the unacceptable rates of Black maternal death

Hubble vs. James Webb telescope images: See the difference

Affirmative action in medical school literally saved lives

CRISPR pioneers react to Casgevy, first gene

Wikipedia

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Anthos stroke drug appears safer than common blood thinner

Congress must reauthorize a committee to support older Americans

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Gain of function research would be limited under House proposal

entertainment

explore

hotspot

entertainment